List of Excipients in API erdafitinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing erdafitinib
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Janssen Products LP | BALVERSA | erdafitinib | 59676-030 | CELLULOSE, MICROCRYSTALLINE | 2036-02-09 |
Janssen Products LP | BALVERSA | erdafitinib | 59676-030 | CROSCARMELLOSE SODIUM | 2036-02-09 |
Janssen Products LP | BALVERSA | erdafitinib | 59676-030 | FERRIC OXIDE YELLOW | 2036-02-09 |
Janssen Products LP | BALVERSA | erdafitinib | 59676-030 | GLYCERYL MONOCAPRYLOCAPRATE | 2036-02-09 |
Janssen Products LP | BALVERSA | erdafitinib | 59676-030 | MAGNESIUM STEARATE | 2036-02-09 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for erdafitinib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
erdafitinib drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | erdafitinib | 59676-030 |
>Company | >Ingredient | >NDC |
erdafitinib drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
erdafitinib drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | erdafitinib | 59676-030 |
>Company | >Ingredient | >NDC |
erdafitinib drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
erdafitinib drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | erdafitinib | 59676-030 |
>Company | >Ingredient | >NDC |
erdafitinib drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE
erdafitinib drug variants containing GLYCERYL MONOCAPRYLOCAPRATE
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | erdafitinib | 59676-030 |
>Company | >Ingredient | >NDC |
erdafitinib drug variants not containing GLYCERYL MONOCAPRYLOCAPRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
erdafitinib drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | erdafitinib | 59676-030 |
>Company | >Ingredient | >NDC |
erdafitinib drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
erdafitinib drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | erdafitinib | 59676-030 |
>Company | >Ingredient | >NDC |
erdafitinib drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MEGLUMINE
erdafitinib drug variants containing MEGLUMINE
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | erdafitinib | 59676-030 |
>Company | >Ingredient | >NDC |
erdafitinib drug variants not containing MEGLUMINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
erdafitinib drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | erdafitinib | 59676-030 |
>Company | >Ingredient | >NDC |
erdafitinib drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
erdafitinib drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | erdafitinib | 59676-030 |
>Company | >Ingredient | >NDC |
erdafitinib drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
erdafitinib drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | erdafitinib | 59676-030 |
>Company | >Ingredient | >NDC |
erdafitinib drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
erdafitinib drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Janssen Products LP | erdafitinib | 59676-030 |
>Company | >Ingredient | >NDC |
erdafitinib drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.